Login / Signup

RSF-1 siRNA Enhances Tumor Radiosensitivity in Cervical Cancer via Enhanced DNA Damage, Cell Cycle Redistribution, and Promotion of Apoptosis.

Jing TianEnqi KongXiangyu WangZhaoguang XieCherry Yin-Yi ChangJim Jinn-Chyuan SheuQuan HaoLi Sun
Published in: OncoTargets and therapy (2020)
These data demonstrate that RSF-1 siRNA enhanced the sensitivity of radiotherapy, and targeting RSF-1 may be a promising approach for the development of novel radiosensitizing agents for the treatment of cervical cancer.
Keyphrases